0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Pain
 41-60 of 181 Articles
Special Feature |  FREE
Evan M. Renz, MD; Geoffrey Ling, MD, PhD; Kevin J. Mork, MD; et al.
Arch Surg. 2012;147(4):391-392. doi:10.1001/archsurg.2011.872a.

Original Article |  FREE
Hasan H. Eker, MD; Hester R. Langeveld, MD; Pieter J. Klitsie, MD; et al.
Arch Surg. 2012;147(3):256-260. doi:10.1001/archsurg.2011.2023.

Review Article |  FREE
Hagar Mizrahi, MD; Michael C. Parker, FRCS
Arch Surg. 2012;147(3):277-281. doi:10.1001/archsurg.2011.914.

Invited Critique | 
David W. Rattner, MD
Arch Surg. 2011;146(12):1366-1367. doi:10.1001/archsurg.2011.299.

Original Article |  FREE
Hsiao-Wen Tsai, MD; Yi-Jen Chen, MD, PhD; Chiu-Ming Ho, MD, PhD; et al.
Arch Surg. 2011;146(12):1360-1366. doi:10.1001/archsurg.2011.597.

Special Feature |  FREE
Andre Grisham, MD; Ramin Javan, MD
Arch Surg. 2011;146(11):1329. doi:10.1001/archsurg.2011.279-a.

Special Feature |  FREE
Arch Surg. 2011;146(9):1096-1097. doi:10.1001/archsurg.2011.241-b.

Correspondence | 
Pankaj Garg, MBBS, MS; Nikhilesh Nain, MBBS
Arch Surg. 2011;146(8):992-993. doi:10.1001/archsurg.2011.190.

Special Feature |  FREE
Reto Kaderli, MD; René Fahrner, MD; Guido Beldi, MD; et al.
Arch Surg. 2011;146(6):759. doi:10.1001/archsurg.2011.140-a.

Special Feature |  FREE
Arch Surg. 2011;146(5):628. doi:10.1001/archsurg.2011.99-b.

Special Feature |  FREE
Jorge Huaco Cateriano, MD; Kenneth W. Gow, MD
Arch Surg. 2011;146(5):629. doi:10.1001/archsurg.2011.107-a.

Original Article |  FREE
Matthew C. Koopmann, MD; Brett H. Yamane, MD; James R. Starling, MD
Arch Surg. 2011;146(4):427-431. doi:10.1001/archsurg.2011.49.

Special Feature |  FREE
Dharmesh Kaswala, MD; Nitin Patel, MD; Sushil Ahlawat, MD
Arch Surg. 2011;146(2):235. doi:10.1001/archsurg.2010.341-a.

Special Feature |  FREE
Arch Surg. 2011;146(2):238. doi:10.1001/archsurg.2010.339-b.

Original Article |  FREE
Bengt Novik, MD; Pär Nordin, MD, PhD; Stefan Skullman, MD, PhD; et al.
Arch Surg. 2011;146(1):12-17. doi:10.1001/archsurg.2010.302.

Special Feature |  FREE
Hemali Trivedi, MD; Ido Nachmany, MD; Parmjeet Randhawa, MD; et al.
Arch Surg. 2010;145(12):1209. doi:10.1001/archsurg.2010.274-a.

Special Feature |  FREE
Faith Dorsey, MD; Melissa W. Taggart, MD; William E. Fisher, MD
Arch Surg. 2010;145(9):913. doi:10.1001/archsurg.2010.172-a.

Special Feature |  FREE
David F. Schneider, MD; Francis J. Harford, MD; Joshua M. Eberhardt, MD
Arch Surg. 2010;145(6):595. doi:10.1001/archsurg.2010.93-a.

Special Feature |  FREE
Matthew G. Stanwix, MD; Barish H. Edil, MD
Arch Surg. 2010;145(5):499. doi:10.1001/archsurg.2010.60-a.

Special Feature |  FREE
Christopher J. Barreiro, MD; Elliott R. Haut, MD
Arch Surg. 2010;145(4):395. doi:10.1001/archsurg.2010.43-a.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Internal Medicine
Original Investigation  | 
Risk for Clinically Relevant Adverse Cardiac Events in Patients With Chest Pain at Hospital Admission
Michael B. Weinstock, MD; Scott Weingart, MD; Frank Orth, DO; et al.
JAMA Neurology
Editorial  | 
Targeting the Interleukin 6 Receptor to Treat Neuromyelitis Optica
Sarosh R. Irani, MD, DPhil; Angela Vincent, FRCPath
JAMA Neurology
Original Investigation  | 
Long-term Therapy With Interleukin 6 Receptor Blockade in Highly Active Neuromyelitis Optica Spectrum Disorder
Marius Ringelstein, MD; Ilya Ayzenberg, MD; Jens Harmel, MD; et al.
JAMA Dermatology
Research Letter  | 
Topically Applied Midodrine, 0.2%, an α1-Agonist, for the Treatment of Erythromelalgia
Mark D. P. Davis, MD; Claudia S. Morr, MD; Roger A. Warndahl, BS Pharm; et al.